Economic CompetitionHealth Care SectorCommerceMarketingMarketing of Health ServicesInvestmentsMolecular StructureStructure-Activity RelationshipDrug IndustryHealth Facility MergerAntitrust LawsMagnetic Resonance SpectroscopyUnited StatesInsurance PoolsStereoisomerismInsurance Selection BiasHealth Care ReformHematoporphyrin DerivativeFinancial ManagementIndicators and ReagentsPatents as TopicEconomics, HospitalLegislation, DrugMolecular Sequence DataChromatography, High Pressure LiquidTax ExemptionKineticsManaged CompetitionTobacco IndustryModels, EconomicHealth Benefit Plans, EmployeeCost ControlSpectrophotometry, UltravioletPrivatizationModels, EconometricCatchment Area (Health)Health Maintenance OrganizationsOwnershipGovernment RegulationFood AssistanceFees and ChargesPrivate SectorContract ServicesDrug and Narcotic ControlChemistryInhibitory Concentration 50Escherichia coliAdvertising as TopicChemical PhenomenaMolecular ConformationSafety-Based Drug WithdrawalsDrugs, GenericInsurance CarriersRate Setting and ReviewChromatography, Thin LayerManaged Care ProgramsInsurance, HealthHematoporphyrinsRisk Sharing, FinancialConsumer SatisfactionSpectrophotometry, InfraredDrug ApprovalProvider-Sponsored OrganizationsGroup PurchasingPoultryMass SpectrometryBenzene DerivativesDrug DesignBinding SitesAnti-Bacterial AgentsAmino Acid SequenceDrug Screening Assays, AntitumorConsumer Product SafetyModels, MolecularCattleDose-Response Relationship, DrugPoliticsHospital-Physician Joint VenturesFood SupplyCapital FinancingCompetitive Medical PlansHospitals, VoluntaryHealth Services ResearchPublic PolicyCoumarinsHealth PolicyGas Chromatography-Mass SpectrometryCosts and Cost AnalysisOrphan Drug ProductionFinancial Management, HospitalDrug CostsBase SequenceEstersEfficiency, OrganizationalCell LineEmploymentAntineoplastic AgentsHospital VolunteersTime FactorsProduct Surveillance, Postmarketing